Beaumont Financial Advisors, LLC Ginkgo Bioworks Holdings, Inc. Transaction History
Beaumont Financial Advisors, LLC
- $1.1 Billion
- Q2 2024
A detailed history of Beaumont Financial Advisors, LLC transactions in Ginkgo Bioworks Holdings, Inc. stock. As of the latest transaction made, Beaumont Financial Advisors, LLC holds 25,000 shares of DNA stock, worth $9,250. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25,000
Previous 20,000
25.0%
Holding current value
$9,250
Previous $23,000
65.22%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding DNA
# of Institutions
361Shares Held
942MCall Options Held
845KPut Options Held
2.54M-
Viking Global Investors LP143MShares$52.9 Million0.63% of portfolio
-
Baillie Gifford & CO134MShares$49.7 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA126MShares$46.6 Million0.0% of portfolio
-
Black Rock Inc. New York, NY72.9MShares$27 Million0.0% of portfolio
-
Anchorage Capital Group, L.L.C. New York, NY69.9MShares$25.8 Million21.46% of portfolio
About Ginkgo Bioworks Holdings, Inc.
- Ticker DNA
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 1,287,779,968
- Market Cap $476M
- Description
- Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...